Pulmonary toxicity of bleomycin - A case series from a tertiary care center in southern India

Navin Patil, Rinz Mathew Paulose, Karthik Subramanya Udupa, Narayanan Ramakrishna, Talha Ahmed

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Hodgkin’s lymphoma is one of the curable cancers and the standard treatment regimen involves combination chemotherapy involving bleomycin. One of the fatal side effect of bleomycin is pulmonary toxicity. Here we present three cases of Hodgkin’s lymphoma treated with ABVD chemotherapy who had pulmonary toxicity. All three developed bleomycin induced pulmonary toxicity in the form of pulmonary fibrosis during treatment of the disease. Mode of treatment, severity of the condition and the treatment outcome varied among the three.Two recovered following treatment and one patient died due to irreversible pulmonary damage. Causality assessment using Naranjo’s scale gave a score of 7 for case one and three and a score of 6 for case two, both indicating the adverse drug reaction to be a probable bleomycin induced Lung fibrosis.

Original languageEnglish
Pages (from-to)FR01-FR03
JournalJournal of Clinical and Diagnostic Research
Volume10
Issue number4
DOIs
Publication statusPublished - 01-04-2016

Fingerprint

Bleomycin
Tertiary Care Centers
Toxicity
India
Lung
Chemotherapy
Hodgkin Disease
Pulmonary Fibrosis
Therapeutics
Combination Drug Therapy
Drug-Related Side Effects and Adverse Reactions
Causality
Fibrosis
Drug Therapy
Pharmaceutical Preparations
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Clinical Biochemistry

Cite this

@article{35f902dd83d14535a46585253836173b,
title = "Pulmonary toxicity of bleomycin - A case series from a tertiary care center in southern India",
abstract = "Hodgkin’s lymphoma is one of the curable cancers and the standard treatment regimen involves combination chemotherapy involving bleomycin. One of the fatal side effect of bleomycin is pulmonary toxicity. Here we present three cases of Hodgkin’s lymphoma treated with ABVD chemotherapy who had pulmonary toxicity. All three developed bleomycin induced pulmonary toxicity in the form of pulmonary fibrosis during treatment of the disease. Mode of treatment, severity of the condition and the treatment outcome varied among the three.Two recovered following treatment and one patient died due to irreversible pulmonary damage. Causality assessment using Naranjo’s scale gave a score of 7 for case one and three and a score of 6 for case two, both indicating the adverse drug reaction to be a probable bleomycin induced Lung fibrosis.",
author = "Navin Patil and Paulose, {Rinz Mathew} and Udupa, {Karthik Subramanya} and Narayanan Ramakrishna and Talha Ahmed",
year = "2016",
month = "4",
day = "1",
doi = "10.7860/JCDR/2016/18773.7626",
language = "English",
volume = "10",
pages = "FR01--FR03",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "4",

}

Pulmonary toxicity of bleomycin - A case series from a tertiary care center in southern India. / Patil, Navin; Paulose, Rinz Mathew; Udupa, Karthik Subramanya; Ramakrishna, Narayanan; Ahmed, Talha.

In: Journal of Clinical and Diagnostic Research, Vol. 10, No. 4, 01.04.2016, p. FR01-FR03.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pulmonary toxicity of bleomycin - A case series from a tertiary care center in southern India

AU - Patil, Navin

AU - Paulose, Rinz Mathew

AU - Udupa, Karthik Subramanya

AU - Ramakrishna, Narayanan

AU - Ahmed, Talha

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Hodgkin’s lymphoma is one of the curable cancers and the standard treatment regimen involves combination chemotherapy involving bleomycin. One of the fatal side effect of bleomycin is pulmonary toxicity. Here we present three cases of Hodgkin’s lymphoma treated with ABVD chemotherapy who had pulmonary toxicity. All three developed bleomycin induced pulmonary toxicity in the form of pulmonary fibrosis during treatment of the disease. Mode of treatment, severity of the condition and the treatment outcome varied among the three.Two recovered following treatment and one patient died due to irreversible pulmonary damage. Causality assessment using Naranjo’s scale gave a score of 7 for case one and three and a score of 6 for case two, both indicating the adverse drug reaction to be a probable bleomycin induced Lung fibrosis.

AB - Hodgkin’s lymphoma is one of the curable cancers and the standard treatment regimen involves combination chemotherapy involving bleomycin. One of the fatal side effect of bleomycin is pulmonary toxicity. Here we present three cases of Hodgkin’s lymphoma treated with ABVD chemotherapy who had pulmonary toxicity. All three developed bleomycin induced pulmonary toxicity in the form of pulmonary fibrosis during treatment of the disease. Mode of treatment, severity of the condition and the treatment outcome varied among the three.Two recovered following treatment and one patient died due to irreversible pulmonary damage. Causality assessment using Naranjo’s scale gave a score of 7 for case one and three and a score of 6 for case two, both indicating the adverse drug reaction to be a probable bleomycin induced Lung fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=84963516773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963516773&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2016/18773.7626

DO - 10.7860/JCDR/2016/18773.7626

M3 - Article

AN - SCOPUS:84963516773

VL - 10

SP - FR01-FR03

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 4

ER -